Reported about 10 hours ago
The Trump administration has intensified its efforts to reduce drug prices and reshape the pharmaceutical supply chain, as expressed by special adviser Calley Means. The administration aims to align U.S. drug prices with those in Europe without mandating specific amounts. Despite drug companies threatening to withdraw manufacturing commitments, Means called such actions 'morally reprehensible.' The administration has introduced tariffs on medical devices and is considering a significant tariff on imported medicines while enforcing a 'Most Favored Nation' executive order to ensure fairness in pricing across developed nations.
Source: YAHOO